Balyasny Asset Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-35,624
| Closed | -$11.7M | – | 2463 |
|
|
2024
Q4 | $11.7M | Buy |
+35,624
| New | +$11.7M | 0.02% | 636 |
|
|
2024
Q3 | – | Sell |
-4,148
| Closed | -$1.37M | – | 2408 |
|
|
2024
Q2 | $1.37M | Sell |
4,148
-3,034
| -42% | -$999K | ﹤0.01% | 1158 |
|
|
2024
Q1 | $2.84M | Sell |
7,182
-206,343
| -97% | -$81.7M | 0.01% | 1003 |
|
|
2023
Q4 | $75.2M | Buy |
213,525
+6,521
| +3% | +$2.3M | 0.14% | 122 |
|
|
2023
Q3 | $77.7M | Buy |
+207,004
| New | +$77.7M | 0.16% | 122 |
|
|
2023
Q1 | – | Sell |
-21,065
| Closed | -$4.96M | – | 2694 |
|
|
2022
Q4 | $4.96M | Buy |
+21,065
| New | +$4.96M | 0.01% | 772 |
|
|
2021
Q4 | – | Sell |
-15,150
| Closed | -$6.43M | – | 2345 |
|
|
2021
Q3 | $6.43M | Buy |
+15,150
| New | +$6.43M | 0.03% | 608 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 2108 |
|
|
2021
Q1 | – | Sell |
-28,646
| Closed | -$8.12M | – | 1924 |
|
|
2020
Q4 | $8.12M | Sell |
28,646
-20,208
| -41% | -$5.73M | 0.05% | 439 |
|
|
2020
Q3 | $13.4M | Buy |
48,854
+38,506
| +372% | +$10.6M | 0.1% | 262 |
|
|
2020
Q2 | $2.35M | Buy |
+10,348
| New | +$2.35M | 0.02% | 550 |
|
|
2019
Q4 | – | Sell |
-2,983
| Closed | -$423K | – | 1387 |
|
|
2019
Q3 | $423K | Sell |
2,983
-16,502
| -85% | -$2.34M | ﹤0.01% | 849 |
|
|
2019
Q2 | $2.44M | Buy |
+19,485
| New | +$2.44M | 0.02% | 694 |
|
|
2019
Q1 | – | Sell |
-8,305
| Closed | -$814K | – | 1552 |
|
|
2018
Q4 | $814K | Buy |
+8,305
| New | +$814K | 0.01% | 866 |
|
|
2018
Q2 | – | Sell |
-17,229
| Closed | -$1.52M | – | 1950 |
|
|
2018
Q1 | $1.52M | Buy |
17,229
+8,179
| +90% | +$722K | 0.01% | 896 |
|
|
2017
Q4 | $893K | Buy |
9,050
+3,826
| +73% | +$378K | ﹤0.01% | 1135 |
|
|
2017
Q3 | $503K | Sell |
5,224
-3,638
| -41% | -$350K | ﹤0.01% | 1152 |
|
|
2017
Q2 | $838K | Sell |
8,862
-4,331
| -33% | -$410K | ﹤0.01% | 959 |
|
|
2017
Q1 | $1.08M | Buy |
13,193
+6,893
| +109% | +$563K | 0.01% | 902 |
|
|
2016
Q4 | $534K | Buy |
+6,300
| New | +$534K | ﹤0.01% | 941 |
|